Bexar Biomedical offers combined technology from MA (Paul Fenton, Ralph Johnston, Jeff Johnston) and UTSA (Doug Frantz, Lyle Hood). We are developing a mini-Intrathecal drug delivery system (pump and catheter, “MiniFuse”) to provide central nervous system (CNS) access for drugs across the blood: brain barrier.
Implantable pumps have been on the market since the early 1980’s from Infusaid Corporation, later Pfizer Infusaid, Medtronic and Flowonics. Infusaid pioneered the first pump that was mechanical, gas-powered (freon), non-electric, and externally refillable, (50ml) initially indicated to treat metastatic liver cancer. Subsequently, the pumps were applied to pain management for cancer, chronic pain syndromes, and spasticity.
Bexar Biomedical is advancing the state of the art with a smaller 15ml mini-pump to reduce size, cost, and improve compatibility with newer drugs. Our team is comprised of engineers, medicinal chemist, and marketeers.